Phase I, Dose Escalation Clinical Trial of GRASPA (Red Blood Cells Encapsulating L-Asparaginase) in Patients With Pancreatic Carcinoma.
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2015
At a glance
- Drugs ERY-ASP (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Sponsors ERYtech Pharma
- 20 Oct 2015 Results published in the October 2015 issue of Pancreas, according to an ERYtech Pharma media release.
- 02 Feb 2012 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.